診斷心電圖市場 - 全球市場規模、佔有率、趨勢分析、機遇和預測報告，2019-2029

到 2029 年，全球診斷心電圖 (ECG) 市場規模將達到 113.3 億美元

由於對即時護理 (POC) 心電圖設備的需求不斷增加、心電圖技術進步的迅速採用以及心血管疾病 (CVD) 患病率的不斷增加，全球診斷心電圖 (ECG) 市場正在蓬勃發展。

領先的戰略諮詢和市場研究公司 BlueWeave Consulting 最近估計，2022 年全球診斷心電圖 (ECG) 市場價值將達到 78.9 億美元。 BlueWeave 預測，2023-2029 年預測期內，全球診斷心電圖 (ECG) 市場規模將以 5.43% 的年複合成長率大幅成長，到 2029 年將達到 113.3 億美元。全球診斷心電圖 (ECG) 市場的主要成長促進因素包括心血管疾病 (CVD) 患病率的上升、老年人口的增加以及技術進步的快速採用。人口老齡化、醫療基礎設施改善以及支持性報銷政策進一步推動了診斷心電圖機的全球市場成長。此外，心電圖技術的持續進步和遠程監控設備的引入預計將在短期內促進市場擴張。新興經濟體比已開發經濟體提供更大的成長潛力，而已開發經濟體的市場已接近飽和。這些地區預計將受益於有利的政府政策、不斷成長的醫療保健支出、尚未開發的潛在市場等，為市場成長創造利潤豐厚的機會。因此，這些方面預計將在預測期內推動整體市場的擴張。然而，心電圖設備的高成本和心電圖測試意識的缺乏預計將抑制整個市場的成長。

該報告的詳細分析提供了有關全球診斷心電圖（ECG）市場的成長潛力、未來趨勢和統計數據的資訊。它還涵蓋了推動市場總規模預測的因素。該報告承諾為決策者提供全球診斷心電圖（ECG）市場的最新技術發展以及行業見解，以做出明智的戰略決策。它還分析了市場的成長促進因素、挑戰和競爭力。

目錄

第1章 研究框架

第2章 執行摘要

第3章 全球診斷心電圖（ECG）市場洞察

• 行業價值鏈分析
• DROC分析
  • 成長促進因素
    • 心血管疾病（CVD）患病率增加
    • 對即時 (POC) 心電圖設備的需求不斷成長
    • 心電圖技術的技術進步
  • 抑制因素
    • 心電圖設備成本高
    • 缺乏心電圖意識
  • 機會
    • 開發具有先進功能的新型心電圖設備
    • 拓展新興市場
  • 任務
    • 嚴格的監管要求
    • 心電圖關鍵技術專利到期
• 技術進步/最新發展
• 監管框架
• 波特五力分析

第4章 全球診斷心電圖 (ECG) 市場概述

• 2019-2029年市場規模及預測
  • 按金額
• 市場佔有率及預測
  • 按產品和服務
    • 靜息心電圖
    • 負荷心電圖裝置
    • 動態心電圖監測儀
    • 嵌入式循環錄音機
    • 事件監視器
    • MCT裝置
    • 智慧心電監護儀
  • 按最終用戶
    • 醫院
    • 診所和心臟中心
    • 日間手術中心
    • 其他
  • 按引線類型
    • 12導聯心電圖儀
    • 5導聯心電圖儀
    • 3 導聯心電圖設備
    • 6導聯心電圖儀
    • 單導聯
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區 (APAC)
    • 拉丁美洲 (LATAM)
    • 中東和非洲 (MEA)

第5章 北美診斷心電圖（ECG）市場

• 2019-2029年市場規模及預測
  • 按金額
• 市場佔有率及預測
  • 按產品和服務
  • 按最終用戶
  • 按引線類型
  • 按國家/地區
    • 美國
    • 加拿大

第6章 歐洲診斷心電圖（ECG）市場

• 2019-2029年市場規模及預測
  • 按金額
• 市場佔有率及預測
  • 按產品和服務
  • 按最終用戶
  • 按引線類型
  • 按國家/地區
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 比利時
    • 俄羅斯
    • 荷蘭
    • 其他歐洲國家

第7章 亞太診斷心電圖（ECG）市場

• 2019-2029年市場規模及預測
  • 按金額
• 市場佔有率及預測
  • 按產品和服務
  • 按最終用戶
  • 按引線類型
  • 按國家/地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞和紐西蘭
    • 印度尼西亞
    • 馬來西亞
    • 新加坡
    • 越南
    • 亞太地區其他地區

第8章 拉丁美洲診斷心電圖（ECG）市場

• 2019-2029年市場規模及預測
  • 按金額
• 市場佔有率及預測
  • 按產品和服務
  • 按最終用戶
  • 按引線類型
  • 按國家/地區
    • 巴西
    • 墨西哥
    • 阿根廷
    • 秘魯
    • 拉丁美洲其他地區

第9章 中東和非洲診斷心電圖（ECG）市場

• 2019-2029年市場規模及預測
  • 按金額
• 市場佔有率及預測
  • 按產品和服務
  • 按最終用戶
  • 按引線類型
  • 按國家/地區
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 科威特
    • 南非
    • 奈及利亞
    • 阿爾及利亞
    • MEA 的其餘部分

第10章 競爭格局

• 主要公司及其產品列表
• 2022 年全球診斷心電圖 (ECG) 市場佔有率分析
• 通過運行參數進行競爭基準測試
• 主要戰略發展（合併、收購、合作夥伴關係等）

第11章COVID-19 對全球診斷心電圖 (ECG) 市場的影響

第12章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭、聯繫地址、戰略展望、SWOT分析）

• Roche Diagnostics
• Abbott Laboratories
• Cepheid Inc.
• BioMerieux SA
• Hologic, Inc.
• QIAGEN NV
• Becton, Dickinson and Company
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Sysmex Corporation
• GenMark Diagnostics, Inc.
• Grifols SA
• Meridian Bioscience, Inc.
• Luminex Corporation
• T2 Biosystems, Inc.
• Other Prominent Players

第13章關鍵戰略建議

第14章調查方法

• 定性研究
  • 初級和次級研究
• 定量研究
• 市場細分和數據三角測量
  • 二次調查
  • 初步調查
• 主要調查受訪者的地區分佈
• 假設和限制

Global Diagnostic Electrocardiograph (ECG) Market Size Set to Touch USD 11.33 Billion by 2029.

Global diagnostic electrocardiograph (ECG) market is flourishing, because of an increasing demand for point-of-care (POC) ECG devices, rapid adoption of technological advancements in ECG technology, and growing prevalence of cardiovascular diseases (CVDs).

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global diagnostic electrocardiograph (ECG) market size at USD 7.89 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global diagnostic electrocardiograph (ECG) market size to grow at a significant CAGR of 5.43% reaching a value of USD 11.33 billion by 2029. Major growth drivers for the global diagnostic electrocardiograph (ECG) market include the rising prevalence of cardiovascular diseases (CVDs), growing geriatric population, and rapid adoption of advancements in technology. An increasing number of elderly individuals, improvements in healthcare infrastructure, and supportive reimbursement policies are further driving the global diagnostic ECG market growth. Also, the continuous advancements in ECG technology, along with the introduction of remote monitoring devices, are expected to contribute to the market's expansion in the foreseeable future. Compared to developed countries where the market is nearly saturated, developing nations offer significant growth prospects. These regions are expected to benefit from favorable government policies, increased healthcare expenditure, and largely untapped potential markets, thereby creating lucrative opportunities for market growth. Hence, such aspects are expected to boost the expansion of overall market during the forecast period. However, the high cost of ECG devices and lack of awareness about ECG testing are anticipated to restrain the overall market growth.

Global Diagnostic Electrocardiograph (ECG) Market - Overview:

The global diagnostic electrocardiograph (ECG) market refers to the worldwide market for medical devices used to measure and record the electrical activity of the heart, known as electrocardiograms (ECGs or EKGs). These devices are essential in assessing cardiac health, diagnosing heart conditions, and monitoring patients with cardiovascular diseases. The market encompasses a range of ECG devices, including resting ECG systems, stress ECG systems, Holter monitors, and event monitors. It plays a crucial role in early detection, diagnosis, and management of cardiovascular diseases, contributing to improved patient care and outcomes. The market is influenced by factors such as the prevalence of cardiovascular diseases, advancements in technology, aging population, and healthcare expenditure.

Impact of COVID-19 on Global Diagnostic Electrocardiograph (ECG) Market:

COVID-19 pandemic had a dual impact on the global diagnostic electrocardiograph (ECG) market. Initially, the market experienced a decline in demand due to the diversion of healthcare resources and priorities towards managing the pandemic. Many non-essential procedures, including routine cardiac screenings, were postponed or canceled. However, as the pandemic progressed, there had been a growing recognition of the importance of cardiac monitoring in COVID-19 patients, leading to increased demand for diagnostic electrocardiograph (ECG) devices. Additionally, the adoption of telemedicine and remote patient monitoring solutions surged, driving the need for portable and home-based ECG devices. These factors are expected to have a positive influence on the market's recovery and growth in the coming years.

Global Diagnostic Electrocardiograph (ECG) Market - By Lead Type:

Based on lead type, the global diagnostic electrocardiograph (ECG) market is divided into 12-lead ECG Devices, 5-lead ECG Devices, 3-lead ECG Devices, 6-lead ECG Devices, and Single-lead segments. The 3-lead ECG devices segment holds the highest share in the global diagnostic electrocardiograph (ECG) market by lead type. These devices are widely used and preferred in healthcare settings due to their simplicity and cost-effectiveness. They provide basic cardiac monitoring by measuring electrical activity from three specific leads, making them suitable for routine screenings and initial assessments. This makes them accessible and affordable for healthcare facilities, especially in resource-constrained settings. Also, 3-lead ECG devices are commonly utilized in various healthcare settings, including hospitals, clinics, and ambulatory care centers, where they offer quick and convenient ECG readings. Their ease of use, affordability, and versatility contribute to their dominant market share.

Competitive Landscape:

Major players operating in the global diagnostic electrocardiograph (ECG) market include: Roche Diagnostics, Abbott Laboratories, Cepheid Inc., BioMerieux SA, Hologic, Inc., QIAGEN N.V., Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Sysmex Corporation, GenMark Diagnostics, Inc., Grifols SA, Meridian Bioscience, Inc., Luminex Corporation, and T2 Biosystems, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Diagnostic Electrocardiograph (ECG) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Diagnostic Electrocardiograph (ECG) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Diagnostic Electrocardiograph (ECG) Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing prevalence of cardiovascular diseases (CVDs)
    • 3.2.1.2. Rising demand for point-of-care (POC) ECG devices
    • 3.2.1.3. Technological advancements in ECG technology
  • 3.2.2. Restraints
    • 3.2.2.1. High cost of ECG devices
    • 3.2.2.2. Lack of awareness about ECG testing
  • 3.2.3. Opportunities
    • 3.2.3.1. Development of new ECG devices with advanced features
    • 3.2.3.2. Expansion into emerging markets
  • 3.2.4. Challenges
    • 3.2.4.1. Stringent regulatory requirements
    • 3.2.4.2. Patent expiration of key ECG technologies
• 3.3. Technology Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Diagnostic Electrocardiograph (ECG) Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Million)
• 4.2. Market Share and Forecast
  • 4.2.1. By Product and Service
    • 4.2.1.1. Resting ECG
    • 4.2.1.2. Stress ECG Devices
    • 4.2.1.3. Holter Monitors
    • 4.2.1.4. Implantable Loop Recorders
    • 4.2.1.5. Event Monitors
    • 4.2.1.6. MCT Devices
    • 4.2.1.7. Smart ECG Monitors
  • 4.2.2. By End User
    • 4.2.2.1. Hospitals
    • 4.2.2.2. Clinics & Cardiac Centers
    • 4.2.2.3. Ambulatory Surgical Centers
    • 4.2.2.4. Others
  • 4.2.3. By Lead Type
    • 4.2.3.1. 12-lead ECG Devices
    • 4.2.3.2. 5-lead ECG Devices
    • 4.2.3.3. 3-lead ECG Devices
    • 4.2.3.4. 6-lead ECG Devices
    • 4.2.3.5. Single-lead
    • 4.2.3.6. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia Pacific (APAC)
    • 4.2.4.4. Latin America (LATAM)
    • 4.2.4.5. Middle East and Africa (MEA)

5. North America Diagnostic Electrocardiograph (ECG) Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Million)
• 5.2. Market Share & Forecast
  • 5.2.1. By Product and Service
  • 5.2.2. By End User
  • 5.2.3. By Lead Type
  • 5.2.4. By Country
    • 5.2.4.1. United States
    • 5.2.4.1.1. By Product and Service
    • 5.2.4.1.2. By End User
    • 5.2.4.1.3. By Lead Type
    • 5.2.4.2. Canada
    • 5.2.4.2.1. By Product and Service
    • 5.2.4.2.2. By End User
    • 5.2.4.2.3. By Lead Type

6. Europe Diagnostic Electrocardiograph (ECG) Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Million)
• 6.2. Market Share & Forecast
  • 6.2.1. By Product and Service
  • 6.2.2. By End User
  • 6.2.3. By Lead Type
  • 6.2.4. By Country
    • 6.2.4.1. Germany
    • 6.2.4.1.1. By Product and Service
    • 6.2.4.1.2. By End User
    • 6.2.4.1.3. By Lead Type
    • 6.2.4.2. United Kingdom
    • 6.2.4.2.1. By Product and Service
    • 6.2.4.2.2. By End User
    • 6.2.4.2.3. By Lead Type
    • 6.2.4.3. Italy
    • 6.2.4.3.1. By Product and Service
    • 6.2.4.3.2. By End User
    • 6.2.4.3.3. By Lead Type
    • 6.2.4.4. France
    • 6.2.4.4.1. By Product and Service
    • 6.2.4.4.2. By End User
    • 6.2.4.4.3. By Lead Type
    • 6.2.4.5. Spain
    • 6.2.4.5.1. By Product and Service
    • 6.2.4.5.2. By End User
    • 6.2.4.5.3. By Lead Type
    • 6.2.4.6. Belgium
    • 6.2.4.6.1. By Product and Service
    • 6.2.4.6.2. By End User
    • 6.2.4.6.3. By Lead Type
    • 6.2.4.7. Russia
    • 6.2.4.7.1. By Product and Service
    • 6.2.4.7.2. By End User
    • 6.2.4.7.3. By Lead Type
    • 6.2.4.8. The Netherlands
    • 6.2.4.8.1. By Product and Service
    • 6.2.4.8.2. By End User
    • 6.2.4.8.3. By Lead Type
    • 6.2.4.9. Rest of Europe
    • 6.2.4.9.1. By Product and Service
    • 6.2.4.9.2. By End User
    • 6.2.4.9.3. By Lead Type

7. Asia-Pacific Diagnostic Electrocardiograph (ECG) Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Product and Service
  • 7.2.2. By End User
  • 7.2.3. By Lead Type
  • 7.2.4. By Country
    • 7.2.4.1. China
    • 7.2.4.1.1. By Product and Service
    • 7.2.4.1.2. By End User
    • 7.2.4.1.3. By Lead Type
    • 7.2.4.2. India
    • 7.2.4.2.1. By Product and Service
    • 7.2.4.2.2. By End User
    • 7.2.4.2.3. By Lead Type
    • 7.2.4.3. Japan
    • 7.2.4.3.1. By Product and Service
    • 7.2.4.3.2. By End User
    • 7.2.4.3.3. By Lead Type
    • 7.2.4.4. South Korea
    • 7.2.4.4.1. By Product and Service
    • 7.2.4.4.2. By End User
    • 7.2.4.4.3. By Lead Type
    • 7.2.4.5. Australia & New Zealand
    • 7.2.4.5.1. By Product and Service
    • 7.2.4.5.2. By End User
    • 7.2.4.5.3. By Lead Type
    • 7.2.4.6. Indonesia
    • 7.2.4.6.1. By Product and Service
    • 7.2.4.6.2. By End User
    • 7.2.4.6.3. By Lead Type
    • 7.2.4.7. Malaysia
    • 7.2.4.7.1. By Product and Service
    • 7.2.4.7.2. By End User
    • 7.2.4.7.3. By Lead Type
    • 7.2.4.8. Singapore
    • 7.2.4.8.1. By Product and Service
    • 7.2.4.8.2. By End User
    • 7.2.4.8.3. By Lead Type
    • 7.2.4.9. Vietnam
    • 7.2.4.9.1. By Product and Service
    • 7.2.4.9.2. By End User
    • 7.2.4.9.3. By Lead Type
    • 7.2.4.10. Rest of APAC
    • 7.2.4.10.1. By Product and Service
    • 7.2.4.10.2. By End User
    • 7.2.4.10.3. By Lead Type

8. Latin America Diagnostic Electrocardiograph (ECG) Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Product and Service
  • 8.2.2. By End User
  • 8.2.3. By Lead Type
  • 8.2.4. By Country
    • 8.2.4.1. Brazil
    • 8.2.4.1.1. By Product and Service
    • 8.2.4.1.2. By End User
    • 8.2.4.1.3. By Lead Type
    • 8.2.4.2. Mexico
    • 8.2.4.2.1. By Product and Service
    • 8.2.4.2.2. By End User
    • 8.2.4.2.3. By Lead Type
    • 8.2.4.3. Argentina
    • 8.2.4.3.1. By Product and Service
    • 8.2.4.3.2. By End User
    • 8.2.4.3.3. By Lead Type
    • 8.2.4.4. Peru
    • 8.2.4.4.1. By Product and Service
    • 8.2.4.4.2. By End User
    • 8.2.4.4.3. By Lead Type
    • 8.2.4.5. Rest of LATAM
    • 8.2.4.5.1. By Product and Service
    • 8.2.4.5.2. By End User
    • 8.2.4.5.3. By Lead Type

9. Middle East & Africa Diagnostic Electrocardiograph (ECG) Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Product and Service
  • 9.2.2. By End User
  • 9.2.3. By Lead Type
  • 9.2.4. By Country
    • 9.2.4.1. Saudi Arabia
    • 9.2.4.1.1. By Product and Service
    • 9.2.4.1.2. By End User
    • 9.2.4.1.3. By Lead Type
    • 9.2.4.2. UAE
    • 9.2.4.2.1. By Product and Service
    • 9.2.4.2.2. By End User
    • 9.2.4.2.3. By Lead Type
    • 9.2.4.3. Qatar
    • 9.2.4.3.1. By Product and Service
    • 9.2.4.3.2. By End User
    • 9.2.4.3.3. By Lead Type
    • 9.2.4.4. Kuwait
    • 9.2.4.4.1. By Product and Service
    • 9.2.4.4.2. By End User
    • 9.2.4.4.3. By Lead Type
    • 9.2.4.5. South Africa
    • 9.2.4.5.1. By Product and Service
    • 9.2.4.5.2. By End User
    • 9.2.4.5.3. By Lead Type
    • 9.2.4.6. Nigeria
    • 9.2.4.6.1. By Product and Service
    • 9.2.4.6.2. By End User
    • 9.2.4.6.3. By Lead Type
    • 9.2.4.7. Algeria
    • 9.2.4.7.1. By Product and Service
    • 9.2.4.7.2. By End User
    • 9.2.4.7.3. By Lead Type
    • 9.2.4.8. Rest of MEA
    • 9.2.4.8.1. By Product and Service
    • 9.2.4.8.2. By End User
    • 9.2.4.8.3. By Lead Type

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Diagnostic Electrocardiograph (ECG) Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Diagnostic Electrocardiograph (ECG) Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. Roche Diagnostics
• 12.2. Abbott Laboratories
• 12.3. Cepheid Inc.
• 12.4. BioMerieux SA
• 12.5. Hologic, Inc.
• 12.6. QIAGEN N.V.
• 12.7. Becton, Dickinson and Company
• 12.8. Danaher Corporation
• 12.9. Thermo Fisher Scientific Inc.
• 12.10. Sysmex Corporation
• 12.11. GenMark Diagnostics, Inc.
• 12.12. Grifols SA
• 12.13. Meridian Bioscience, Inc.
• 12.14. Luminex Corporation
• 12.15. T2 Biosystems, Inc.
• 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations